Status: Recruiting
Prospective Immuno-Radiomic Profiling in Nasopharyngeal Carcinoma Treated With Proton or Photon Chemoradiotherapy
To prospectively investigate and integrate radiomic and immunologic signatures in patients with nasopharyngeal carcinoma (NPC) treated with either proton or photon radiotherapy, with the aim of identifying biomarkers associated with treatment response, toxicity, and long-term outcomes.
Participants needed: 500
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Cheng-En HsiehUpdated: Nov 24, 2025Locations: 1
Eligibility criteria
Willingness to provide written informed consent. [+11]
Presence of distant metastasis [+5]